跳至主要内容
临床试验/JPRN-UMIN000004930
JPRN-UMIN000004930尚未招募未知

Comparison of Fluticasone Furoate and Fexofenadine hydrochloride as initial treatment for Japanese cedar pollinosis: single-center,randomized,parallel-group study - Comparison of Fluticasone Furoate and Fexofenadine hydrochloride as initial treatment for Japanese cedar pollinosis: single-center,randomized,parallel-group study

Kansai Medical University0 个研究点目标入组 60 人开始时间: 2011年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)patient experienced adverse effect by components of study drug 2)patients who is pregnant or suspected of pregnancy , wish to get pregnant , nursing mom 3)inappropriate patient for this study from the doctor's viewpoint

研究者

相似试验

已完成
不适用
Comparative efficacy of fluticasone furoate/umeclidinium/vilanterol(FF/UMEC/VI)versus budesonide/glycopyrrolate/formoterol fumarate(B/G/F) therapies in COPD patientsCOPD
JPRN-UMIN000041089ippon Koukan Hospital50
进行中(未招募)
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPD
EUCTR2017-004369-29-ESGlaxoSmithKline, S.A.3,000
进行中(未招募)
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPDChronic Obstructive Pulmonary Disease (COPD) which may be called emphysema or chronic bronchitis.MedDRA version: 21.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855
EUCTR2017-004369-29-NLGlaxoSmithKline Research & Development Limited3,341
进行中(未招募)
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPDChronic Obstructive Pulmonary Disease (COPD) which may be called emphysema or chronic bronchitis.MedDRA version: 20.0 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855
EUCTR2017-004369-29-GBGlaxoSmithKline Research & Development Limited3,000
进行中(未招募)
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPDChronic Obstructive Pulmonary Disease (COPD) which may be called emphysema or chronic bronchitis.MedDRA version: 20.0 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855
EUCTR2017-004369-29-SEGlaxoSmithKline Research & Development Limited3,000